These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29528004)

  • 21. Organ Transplantation in Kuwait and the Recent Initiation of a Liver Program.
    Jamal M; AlMahmeed H; AlGhanem M; AlMatooq M; Sadek A; AlMousawi M; Al-Sabah S; Vilca Melendez H; Rela M; Heaton N; Jassem W
    Transplantation; 2021 Oct; 105(10):2125-2127. PubMed ID: 34591813
    [No Abstract]   [Full Text] [Related]  

  • 22. A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis.
    Perumpail RB; Wong RJ; Pham EA; Higgins JP; Daugherty TJ; Ahmed A
    Dig Dis Sci; 2016 Jan; 61(1):39-41. PubMed ID: 26082077
    [No Abstract]   [Full Text] [Related]  

  • 23. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Can we afford organ transplants?].
    Kekomäki M; Höckerstedt K
    Duodecim; 2004; 120(11):1351-2. PubMed ID: 15327087
    [No Abstract]   [Full Text] [Related]  

  • 25. The global role of kidney transplantation.
    Garcia Garcia G; Harden P; Chapman J;
    Arch Iran Med; 2012 Feb; 15(2):102-6. PubMed ID: 22292582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The financial burden after liver transplantation is significant among commercially insured adults: A large US National Cohort.
    Lieber SR; Jiang Y; Jones AR; Gowda P; Ufere NN; Patel MS; Gurley T; Noriega Ramirez A; Ngo VM; Olumesi MC; Trudeau RE; Marrero J; Craddock Lee SJ; Mufti A; Singal AG; VanWagner LB
    Liver Transpl; 2024 Sep; 30(9):932-944. PubMed ID: 38108824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal Function and Transplantation in Liver Disease.
    Parajuli S; Foley D; Djamali A; Mandelbrot D
    Transplantation; 2015 Sep; 99(9):1756-64. PubMed ID: 26308413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.
    Ready AR; Nath J; Milford DV; Adu D; Jewitt-Harris J
    Kidney Int; 2016 Nov; 90(5):916-920. PubMed ID: 27742191
    [No Abstract]   [Full Text] [Related]  

  • 31. Caring for Migrants and Refugees With End-Stage Kidney Disease in Europe.
    Van Biesen W; Vanholder R; Ernandez T; Drewniak D; Luyckx V
    Am J Kidney Dis; 2018 May; 71(5):701-709. PubMed ID: 29274918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kidney dialysis and transplantation].
    Makó J
    Orv Hetil; 2000 Dec; 141(50):2749. PubMed ID: 11189682
    [No Abstract]   [Full Text] [Related]  

  • 33. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
    Wikström B; Fored M; Eichleay MA; Jacobson SH
    Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.
    Saxena V; Lai JC
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):391-8. PubMed ID: 26311601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality.
    Nicolas CT; Nyberg SL; Heimbach JK; Watt K; Chen HS; Hathcock MA; Kremers WK
    Liver Transpl; 2017 Jan; 23(1):11-18. PubMed ID: 27658200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The organization and financing of end-stage renal disease in Spain.
    Luño J
    Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience of combined liver-kidney transplantation for acute-on-chronic liver failure patients with renal dysfunction.
    Xing T; Zhong L; Chen D; Peng Z
    Transplant Proc; 2013; 45(6):2307-13. PubMed ID: 23871182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial burden following adult liver transplantation is common and associated with adverse recipient outcomes.
    Ufere NN; Serper M; Kaplan A; Horick N; Indriolo T; Li L; Satapathy N; Donlan J; Castano Jimenez JC; Lago-Hernandez C; Lieber S; Gonzalez C; Keegan E; Schoener K; Bethea E; Dageforde LA; Yeh H; El-Jawahri A; Park ER; Vodkin I; Schonfeld E; Nipp R; Desai A; Lai JC
    Liver Transpl; 2024 Sep; 30(9):918-931. PubMed ID: 38353602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P; Oberkofler CE; Béchir M; Müllhaupt B; Geier A; Raptis DA; Clavien PA
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal transplantation without dialysis: better results at a lower cost?
    John GT; Viswanathan S
    Natl Med J India; 2001; 14(4):224. PubMed ID: 11547530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.